Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU
The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...
Biolog Purchases Anaerobe Systems, Its Third Acquisition, Becoming the Knowledge Leader in Microbiology Research and Clinical Sample Prep
HAYWARD, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multi ...
Elanco Reinforces Commitment to Veterinary and Pet Owner Education
Elanco Animal Health Incorporated issued the following statement regarding its commitment to clear veterinary and pet owner ...
Illuccix® Approved in the United Kingdom
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) ...
TMCnet1d
Clearsense Announces Strategic Rebrand and Relocation of Headquarters to Nashville
NASHVILLE, Tenn., Feb. 12, 2025 /PRNewswire/ -- Clearsense ®, a cloud-based data enablement platform company, has unveiled a ...
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million– Following ...
IJR1d
Medical Activists Are Behind New Wave Of Anti-Trump Lawfare. Guess What They Did During The COVID Pandemic.
A federal judge ordered health agencies Tuesday to reinstate certain webpages taken down in response to President Donald ...
Cancer research group calls on Trump administration to restore data access
The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.
American Well Corporation (AMWL) Q4 2024 Earnings Call Transcript
American Well Corporation ( NYSE: AMWL) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark ...
Telix Pharmaceuticals Limited: Illuccix Approved in the United Kingdom
Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare ...
manilatimes1d
Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
In the Phase 2 open-label Oral Anaphylm Symptom Intervention Study ("OASIS”) study, adults with Oral Allergy Syndrome (n=36) received Anaphylm under different conditions, including single and repeat ...